Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

[Ocular lymphoma : Precise diagnostics and classification as key for successful personalized treatment].

Kakkassery V, Jünemann AM, Bechrakis NE, Grisanti S, Ranjbar M, Zschoche M, Heindl LM.

Ophthalmologe. 2019 Dec 6. doi: 10.1007/s00347-019-01020-5. [Epub ahead of print] Review. German.

PMID:
31811368
2.

Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy.

Biewald EM, Bornfeld N, Metz KA, Schlüter S, Kiefer T, Radbruch A, Göricke S, Sirin S, Ketteler P, Bechrakis NE.

Br J Ophthalmol. 2019 Nov 1. pii: bjophthalmol-2019-315209. doi: 10.1136/bjophthalmol-2019-315209. [Epub ahead of print]

PMID:
31676593
3.

Ultra-wide-field imaging of choroidal melanoma before and after proton beam radiation therapy.

Psomiadi A, Haas G, Edlinger M, Bechrakis NE, Blatsios G.

Eur J Ophthalmol. 2019 Aug 30:1120672119873210. doi: 10.1177/1120672119873210. [Epub ahead of print]

PMID:
31466473
4.

GNAQ Q209R Mutations Are Highly Specific for Circumscribed Choroidal Hemangioma.

Le Guin CHD, Metz KA, Kreis SH, Bechrakis NE, Bornfeld N, Zeschnigk M, Lohmann DR.

Cancers (Basel). 2019 Jul 22;11(7). pii: E1031. doi: 10.3390/cancers11071031.

5.

Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone Receptor.

Plöhn S, Hose M, Schlüter A, Michel L, Diaz-Cano S, Hendgen-Cotta UB, Banga JP, Bechrakis NE, Hansen W, Eckstein A, Berchner-Pfannschmidt U.

Thyroid. 2019 Sep;29(9):1286-1301. doi: 10.1089/thy.2018.0754.

PMID:
31237525
6.

[Multimodal diagnostic of CSNB1 with NYX gene mutation].

Rating P, Stöhr H, Neuhaus C, Schaperdoth-Gerlings B, Böhm MRR, Freimuth MA, Bechrakis NE.

Ophthalmologe. 2019 Dec;116(12):1207-1211. doi: 10.1007/s00347-019-0886-2. German.

PMID:
30980176
7.

Graves' orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model.

Schlüter A, Flögel U, Diaz-Cano S, Görtz GE, Stähr K, Oeverhaus M, Plöhn S, Mattheis S, Moeller LC, Lang S, Bechrakis NE, Banga JP, Eckstein A, Berchner-Pfannschmidt U.

Sci Rep. 2018 Aug 30;8(1):13096. doi: 10.1038/s41598-018-31253-4.

8.

[Editorial].

Auw-Hädrich C, Bechrakis NE, Bornfeld N.

Klin Monbl Augenheilkd. 2018 Jul;235(7):774-775. doi: 10.1055/a-0600-7415. Epub 2018 Jul 11. German. No abstract available.

PMID:
29996159
9.

Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.

Böker A, Pilger D, Cordini D, Seibel I, Riechardt AI, Joussen AM, Bechrakis NE.

Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1767-1775. doi: 10.1007/s00417-018-4032-7. Epub 2018 Jun 16.

PMID:
29907945
10.

[Unclear uveal tumor with bleeding].

Angermann R, Haas G, Hofer M, Stattin M, Bechrakis NE, Zehetner C.

Ophthalmologe. 2018 Dec;115(12):1070-1072. doi: 10.1007/s00347-018-0650-z. German. No abstract available.

PMID:
29368019
11.

[Rhegmatogenous retinal detachment : Epidemiology and risk factors].

Bechrakis NE, Dimmer A.

Ophthalmologe. 2018 Feb;115(2):163-178. doi: 10.1007/s00347-017-0647-z. German.

PMID:
29352407
12.

Iodine-125 Brachytherapy for Uveal Melanoma: A Systematic Review of Radiation Dose.

Echegaray JJ, Bechrakis NE, Singh N, Bellerive C, Singh AD.

Ocul Oncol Pathol. 2017 Sep;3(3):193-198. doi: 10.1159/000455872. Epub 2017 Feb 8. Review.

13.

IN VITRO FLOW ANALYSIS OF NOVEL DOUBLE-CUTTING, OPEN-PORT, ULTRAHIGH-SPEED VITRECTOMY SYSTEMS.

Zehetner C, Moelgg M, Bechrakis E, Linhart C, Bechrakis NE.

Retina. 2018 Dec;38(12):2309-2316. doi: 10.1097/IAE.0000000000001882.

PMID:
29016453
14.

[Surgical Methods in the Treatment of Uveal Melanoma].

Blatsios G, Haas G, Zehetner C, Bechrakis NE.

Klin Monbl Augenheilkd. 2017 Jul;234(7):874-885. doi: 10.1055/s-0043-114421. Epub 2017 Jul 25. Review. German.

PMID:
28743137
15.

Severe reactive ischemic posterior segment inflammation in Acanthamoeba keratitis: Case report of a patient with Sjögren's syndrome.

Palme C, Steger B, Haas G, Teuchner B, Bechrakis NE.

Spektrum Augenheilkd. 2017;31(1):10-13. doi: 10.1007/s00717-017-0334-0. Epub 2017 Mar 9.

16.

Decreased Vision as Initial Presenting Symptom of Acute Lymphoblastic Leukemia: A Case Report.

Palme C, Bechrakis NE, Stattin M, Haas G, Zehetner C.

Case Rep Ophthalmol. 2016 Jul 21;7(2):377-383. eCollection 2016 May-Aug.

17.

Morphometric characterisation of pterygium associated with corneal stromal scarring using high-resolution anterior segment optical coherence tomography.

Gasser T, Romano V, Seifarth C, Bechrakis NE, Kaye SB, Steger B.

Br J Ophthalmol. 2017 May;101(5):660-664. doi: 10.1136/bjophthalmol-2016-308685. Epub 2016 Aug 3.

PMID:
27488179
18.

[Editorial].

Auw-Hädrich C, Bechrakis NE, Bornfeld N.

Klin Monbl Augenheilkd. 2016 Jul;233(7):807. doi: 10.1055/s-0042-110803. Epub 2016 Jul 28. German. No abstract available.

PMID:
27468095
19.

Correspondence.

Zehetner C, Modi YS, Bechrakis NE.

Retina. 2016 Feb;36(2):e14-5. doi: 10.1097/IAE.0000000000000942. No abstract available.

PMID:
26689271
20.

Myopic foveoschisis: an ectatic retinopathy, not a schisis.

Tsilimbaris MK, Vavvas DG, Bechrakis NE.

Eye (Lond). 2016 Feb;30(2):328-9. doi: 10.1038/eye.2015.233. Epub 2015 Nov 20. No abstract available.

21.

Detection of tumour cells in the bloodstream of patients with uveal melanoma: influence of surgical manipulation on the dissemination of tumour cells in the bloodstream.

Charitoudis G, Schuster R, Joussen AM, Keilholz U, Bechrakis NE.

Br J Ophthalmol. 2016 Apr;100(4):468-72. doi: 10.1136/bjophthalmol-2015-306955. Epub 2015 Aug 17.

PMID:
26283704
22.

Neoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 cases.

Willerding GD, Cordini D, Moser L, Krause L, Foerster MH, Bechrakis NE.

Br J Ophthalmol. 2016 Apr;100(4):463-7. doi: 10.1136/bjophthalmol-2015-307095. Epub 2015 Jul 29.

PMID:
26224096
23.

[Short Review of the History of Radiotherapy for Intraocular Tumours].

Bechrakis NE, Blatsios G, Haas G.

Klin Monbl Augenheilkd. 2015 Jul;232(7):834-7. doi: 10.1055/s-0035-1546187. Epub 2015 Jul 20. Review. German.

PMID:
26193115
24.

[Editorial].

Bechrakis NE, Bornfeld N, Auw-Hädrich C.

Klin Monbl Augenheilkd. 2015 Jul;232(7):833. doi: 10.1055/s-0035-1546189. Epub 2015 Jul 20. German. No abstract available.

PMID:
26193114
25.

Systemic counterregulatory response of placental growth factor levels to intravitreal aflibercept therapy.

Zehetner C, Bechrakis NE, Stattin M, Kirchmair R, Ulmer H, Kralinger MT, Kieselbach GF.

Invest Ophthalmol Vis Sci. 2015 May;56(5):3279-86. doi: 10.1167/iovs.15-16686.

PMID:
26024110
26.

Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospital.

Teuchner B, Wagner J, Bechrakis NE, Orth-Höller D, Nagl M.

Medicine (Baltimore). 2015 Feb;94(8):e583. doi: 10.1097/MD.0000000000000583.

27.

Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age-related macular degeneration: a randomised, prospective trial.

Zehetner C, Kralinger MT, Modi YS, Waltl I, Ulmer H, Kirchmair R, Bechrakis NE, Kieselbach GF.

Acta Ophthalmol. 2015 Mar;93(2):e154-9. doi: 10.1111/aos.12604. Epub 2014 Dec 8.

28.

[Degenerative maculopathy (in younger patients)].

Haas G, Treiblmayr B, Kralinger M, Bechrakis NE.

Klin Monbl Augenheilkd. 2014 Dec;231(12):1239-55. doi: 10.1055/s-0033-1358018. Epub 2014 Nov 13. German. No abstract available.

PMID:
25393434
29.

[Comparison of IOL-Master 500 vs. Lenstar LS900 concerning the calculation of target refraction: A retrospective analysis].

Stattin M, Zehetner C, Bechrakis NE, Speicher L.

Ophthalmologe. 2015 May;112(5):444-50. doi: 10.1007/s00347-014-3143-8. German.

PMID:
25391789
30.

In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease.

Steger B, Speicher L, Philipp W, Bechrakis NE.

Br J Ophthalmol. 2015 Feb;99(2):160-5. doi: 10.1136/bjophthalmol-2014-305072. Epub 2014 Aug 19.

PMID:
25138762
31.

Proton beam therapy leads to excellent local control rates in choroidal melanoma in the intermediate fundus zone.

Schönfeld S, Cordini D, Riechardt AI, Seibel I, Willerding G, Bechrakis NE, Moser L, Joussen AM.

Am J Ophthalmol. 2014 Dec;158(6):1184-91. doi: 10.1016/j.ajo.2014.08.016. Epub 2014 Aug 13.

PMID:
25128597
32.

[Ophthalmopathology].

Auw-Hädrich C, Bechrakis NE, Bornfeld N.

Klin Monbl Augenheilkd. 2014 Jul;231(7):685. doi: 10.1055/s-0034-1368642. Epub 2014 Jul 18. German. No abstract available.

PMID:
25036804
33.

Proton beam therapy of parapapillary choroidal melanoma.

Riechardt AI, Cordini D, Willerding GD, Georgieva I, Weber A, Seibel I, Lakotka N, Bechrakis NE, Foerster MH, Moser L, Joussen AM.

Am J Ophthalmol. 2014 Jun;157(6):1258-65. doi: 10.1016/j.ajo.2014.02.032. Epub 2014 Feb 16.

PMID:
24548873
34.

Systemic upregulation of PDGF-B in patients with neovascular AMD.

Zehetner C, Kirchmair R, Neururer SB, Kralinger MT, Bechrakis NE, Kieselbach GF.

Invest Ophthalmol Vis Sci. 2014 Jan 20;55(1):337-44. doi: 10.1167/iovs.13-12978.

PMID:
24334449
35.

Catestatin-like immunoreactivity in the rat eye.

Gramlich OW, Lorenz K, Grus FH, Kriechbaum M, Ehrlich D, Humpel C, Fischer-Colbrie R, Bechrakis NE, Troger J.

Neuropeptides. 2014 Feb;48(1):7-13. doi: 10.1016/j.npep.2013.11.003. Epub 2013 Nov 25.

PMID:
24331778
36.

[Editorial].

Bornfeld N, Bechrakis NE, Auw-Hädrich C.

Klin Monbl Augenheilkd. 2013 Jul;230(7):676-7. doi: 10.1055/s-0033-1350629. Epub 2013 Jul 22. German. No abstract available.

PMID:
23877819
37.

Staging of ciliary body and choroidal melanomas based on anatomic extent.

Kujala E, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Grange JD, Kivelä T.

J Clin Oncol. 2013 Aug 1;31(22):2825-31. doi: 10.1200/JCO.2012.45.2771. Epub 2013 Jul 1.

PMID:
23816968
38.

Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis.

Dobner BC, Riechardt AI, Joussen AM, Englert S, Bechrakis NE.

Acta Ophthalmol. 2012 Dec;90(8):e638-44. doi: 10.1111/j.1755-3768.2012.02515.x. Epub 2012 Nov 20.

39.

N-chlorotaurine and its analogues N,N-dichloro-2,2-dimethyltaurine and N-monochloro-2,2-dimethyltaurine are safe and effective bactericidal agents in ex vivo corneal infection models.

Teuchner B, Eitzinger C, Lutz M, Hager T, Schmid E, Bechrakis NE, Zuck M, Jekle A, Debabov D, Anderson M, Nagl M.

Acta Ophthalmol. 2012 Dec;90(8):e632-7. doi: 10.1111/j.1755-3768.2012.02501.x. Epub 2012 Sep 12.

40.

Secretoneurin, substance P and neuropeptide Y in the oxygen-induced retinopathy in C57Bl/6N mice.

Schmid E, Nogalo M, Bechrakis NE, Fischer-Colbrie R, Tasan R, Sperk G, Theurl M, Beer AG, Kirchmair R, Herzog H, Troger J.

Peptides. 2012 Oct;37(2):252-7. doi: 10.1016/j.peptides.2012.07.024. Epub 2012 Aug 3.

PMID:
22884536
41.

[Ophthalmopathology].

Auw-Hädrich C, Bechrakis NE, Bornfeld N.

Klin Monbl Augenheilkd. 2012 Jul;229(7):685. doi: 10.1055/s-0032-1315011. Epub 2012 Jul 25. German. No abstract available.

PMID:
22833131
42.

GE-25-like immunoreactivity in the rat eye.

Lorenz K, Gramlich OW, Grus FH, Ehrlich D, Humpel C, Nogalo M, Fischer-Colbrie R, Bechrakis NE, Hattmannstorfer R, Troger J.

Peptides. 2012 Aug;36(2):286-91. doi: 10.1016/j.peptides.2012.04.022. Epub 2012 May 23.

PMID:
22634234
43.

White centered retinal hemorrhages in vitamin b(12) deficiency anemia.

Zehetner C, Bechrakis NE.

Case Rep Ophthalmol. 2011 May;2(2):140-4. doi: 10.1159/000328123. Epub 2011 May 3.

44.

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival.

Giatromanolaki A, Sivridis E, Bechrakis NE, Willerding G, St Charitoudis G, Foerster MH, Gatter KC, Harris AL, Koukourakis MI.

Clin Exp Metastasis. 2012 Jan;29(1):11-7. doi: 10.1007/s10585-011-9424-6. Epub 2011 Oct 9.

PMID:
21984395
45.

Bilateral diffuse uveal melanocytic proliferation associated with the recurrence of a Bartholin gland carcinoma.

Brüggemann A, von Bülow M, Finas D, Bechrakis NE, Hoerauf H, Müller M.

Br J Ophthalmol. 2011 Jun;95(6):888-9, 898. No abstract available.

PMID:
21748875
46.

[Intraocular manifestations of systemic neoplasms].

Bechrakis NE, Haas G, Blatsios G.

Klin Monbl Augenheilkd. 2011 Jul;228(7):586-92. doi: 10.1055/s-0031-1273474. Epub 2011 Jul 7. Review. German.

PMID:
21739400
47.

[Ophthalmological oncology].

Bornfeld N, Bechrakis NE.

Klin Monbl Augenheilkd. 2011 Jul;228(7):585. doi: 10.1055/s-0031-1281585. Epub 2011 Jul 7. German. No abstract available.

PMID:
21739399
48.

Intraoperative localization of tantalum markers for proton beam radiation of choroidal melanoma by an opto-electronic navigation system: a novel technique.

Amstutz CA, Bechrakis NE, Foerster MH, Heufelder J, Kowal JH.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1361-6. doi: 10.1016/j.ijrobp.2011.04.049. Epub 2011 Jun 12.

PMID:
21665382
49.

Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.

Schuster R, Bechrakis NE, Stroux A, Busse A, Schmittel A, Thiel E, Foerster MH, Keilholz U.

Oncology. 2011;80(1-2):57-62. doi: 10.1159/000328283. Epub 2011 May 31.

PMID:
21625180
50.

Autophagy patterns and prognosis in uveal melanomas.

Giatromanolaki AN, Charitoudis GS, Bechrakis NE, Kozobolis VP, Koukourakis MI, Foerster MH, Sivridis EL.

Mod Pathol. 2011 Aug;24(8):1036-45. doi: 10.1038/modpathol.2011.63. Epub 2011 Apr 15.

Supplemental Content

Loading ...
Support Center